Stocks / AXON vs ELVA

Axovant Sciences Ltd. Common Shares (AXON) vs Electrovaya Inc. (ELVA)

Axovant Sciences Ltd. Common Shares and Electrovaya Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.

AXON is the larger company ($51.0B vs $0.5B). On the fundamentals, ELVA grows revenue faster (59.7% vs 32.5%); ELVA earns a higher net margin (5.3% vs 4.5%); ELVA has the stronger return on equity (10.8% vs 3.8%). Over the last five years, AXON returned 230.3% vs 67.2%. On the filings, ELVA carries fewer potential red flags (2 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — AXON vs ELVA, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Axovant Sciences Ltd. Common Shares (AXON)Electrovaya Inc. (ELVA)
Market cap$51.0B$0.5B
Revenue (latest FY)$2.78B$63.58M
Net income (latest FY)$124.66M$3.36M
Revenue growth (5y CAGR)32.5%59.7%
Net margin4.5%5.3%
Return on equity3.8%10.8%
P/E ratio262.784.4
Dividend yield
Profitable years (of last 10)81
Positive free cash flowYesNo

Performance — AXON vs ELVA

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Axovant Sciences Ltd. Common Shares (AXON)Electrovaya Inc. (ELVA)
1-year return-19.6%172.1%
3-year return182.2%154.9%
5-year return230.3%67.2%
10-year return2118.4%-32.0%
52-week range$339.01–$792.16$3.11–$12.78

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full AXON vs ELVA breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open AXON's full financials →   Open ELVA's full financials →

More comparisons

Frequently asked questions

Which is bigger, AXON or ELVA?

Axovant Sciences Ltd. Common Shares is larger by market capitalization — $51.0B versus $0.5B.

Which grows faster, AXON or ELVA?

Over the last five fiscal years, Electrovaya Inc. grew revenue faster — 59.7%/yr versus 32.5%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

AXON fundamentals → · ELVA fundamentals → · All 1,500+ companies → · Free screener →